Anavex Life Sciences NASDAQ: AVXL is a short-squeeze candidate because its share prices are rising on good news, institutional and analyst support is growing, and the short-sellers are selling into the rally. Short interest topped 23% at the end of November and is unlikely to have fallen much since because they spiked to a one-year high, showing a high conviction—plenty of fuel for a short squeeze.  Anavex Life Sciences TodayAVXLAnavex Life Sciences$10.87 -0.31 (-2.77%) 52-Week Range$3.25▼$12.48Price Targe ...